Log In
Print this Print this

Neoral, cyclosporine modified

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
Molecular Target Cyclophilin
Mechanism of ActionCalcineurin inhibitor
Therapeutic ModalityMacrocycle

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today